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Our previous study concerning brain trauma has shown that progesterone could regulate toll-like receptor 4 (TLR4) and nuclear
factor-kappa B (NF-κB) signaling pathway in the brain, which also has been proved to play important roles in early brain injury
(EBI)aftersubarachnoidhemorrhage(SAH).Theaimofthecurrentstudywastoinvestigatewhetherprogesteroneadministration
modulated TLR4/NF-κB pathway signaling pathway in the brain at the early stage of SAH. All SAH animals were subjected
to injection of 0.3ml fresh arterial, non-heparinized blood into prechiasmatic cistern in 20 seconds. Male rats were given 0 or
16mg/kg injections of progesterone at post-SAH hours 1, 6, and 24. Brain samples were extracted at 48h after SAH. As a result,
SAH could induce a strong up-regulation of TLR4, NF-κB, pro-inﬂammatory cytokines, MCP-1, and ICAM-1 in the cortex.
Administration of progesterone following SAH could down-regulate the cortical levels of these agents related to TLR4/NF-κB
signaling pathway. Post-SAH progesterone treatment signiﬁcantly ameliorated the EBI, such as the clinical behavior scale, brain
edema, and blood-brain barrier (BBB) impairment. It was concluded that post-SAH progesterone administration may attenuate
TLR4/NF-κB signaling pathway in the rat brain following SAH.
1.Introduction
Early brain injury (EBI) is the most common cause of
disability and death in patients suﬀering from aneurysmal
subarachnoid hemorrhage (SAH) [1]. Treatment of EBI is
considered as a major goal in the management of patients
surviving SAH. However, the exact molecular mechanism
of EBI still remains obscure, which has hindered the
development of eﬀective and speciﬁc treatment paradigms
for EBI. The term EBI refers to the immediate injury to
the brain as a whole, within the ﬁrst 48h of the ictus,
secondary to SAH [2]. Previous reports [3, 4]h a v ed e m o n -
strated that inﬂammatory responses mediated mainly by the
activation of toll-like receptor 4 and nuclear factor-kappa
B (TLR4/NF-κB) signaling pathway played an important
role in the pathogenesis of EBI following SAH. In their
study, the authors mentioned that E5564 (TLR4 inhibitor)
could correct the neurological deﬁcits and down-regulate
inﬂammation by inhibiting activation of the TLR4/NF-κB
signaling in prechiasmatic blood injection model.
There are now 10 mammalian toll-like receptors (TRLs)
identiﬁed by sequence analysis. Among them, TRL4, which
was widely expressed in brain, can detect endogenous ago-
nists, such as the degradation products of macromolecules,
heat shock protein 60 and 70, products of proteolytic
cascades, intracellular components of ruptured cells, and
products of genes that are activated by inﬂammation
[5]. Furthermore, TLR4 has been demonstrated to play
an important role in initiating the cerebral inﬂammation
related to stroke, Alzheimer’s disease, Huntington’s disease,
and Parkinson’s disease [6]. All TLRs activate a common
signaling pathway that culminates in the activation of NF-
κB transcription factors and the mitogen-activated protein
kinases (MAPKs). As one of the most important down-
stream molecules in TLR4 signaling pathway, NF-κBi sa
transcriptional factor required for the gene expression of
many inﬂammatory mediators, such as interleukin-1β (IL-
1β), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6),
intercellular adhesion molecule-1 (ICAM-1), and monocyte
chemoattractant protein-1 (MCP-1).2 Mediators of Inﬂammation
Recently, several reports from clinical and experimental
studieshavedemonstratedthatprogesteroneplaysneuropro-
tective roles in traumatic brain injury (TBI) and ischemic
brain injury [7] including reducing cerebral edema, prevent-
ing neuronal loss, and improving functional outcomes [8].
At the same time, our previous studies [9, 10]h a v ep r o v e d
that post-TBI progesterone administration attenuated the
TLR4/NF-κB signaling pathway in injured rat brain, which
was a mechanism whereby progesterone improved the out-
come following TBI. Nevertheless till now, it is still unknown
whether progesterone can inﬂuence TLR4/NF-κBp a t h w a y
in the brain after SAH. Thus, the aim of the current study
was to determine whether progesterone could attenuate the
SAHinducedactivationofTLR4/NF-κBsignalingpathwayin
the cortex. We hypothesized that the eﬀect of progesterone
on modulating TLR4/NF-κB signaling pathway could be
a mechanism by which progesterone promoted behavioral
recovery after SAH.
2.MaterialsandMethods
2.1. Animals. The animal use and care protocols, including
all operation procedures, were approved by the Animal Care
and Use Committee of Soochow University and conformed
to the Guide for the Care and Use of Laboratory Animals
by the National Institute of Health. Ninety-six male Sprague
Dawley rats weighing from 280 to 350g were purchased
from the Animal Center of the Chinese Academy of Sciences
(Shanghai, China). They were acclimated in a humidiﬁed
room and maintained on the standard pellet diet at the
Animal Center of Soochow University for 10 days before the
experiment. The temperature in both the feeding room and
the operation room was maintained at about 25◦C.
2.2. Prechiasmatic Cistern SAH Model. Following intraperi-
toneal anesthesia with 4% chloral hydrate (400mg/kg body
weight), animal head was ﬁxed in the stereotactic frame.
Experimental SAH model was produced using stereotaxic
insertion of a needle with a rounded tip and a side hole
into the prechiasmatic cistern according to our previous
study [11]. The needle was tilted 45◦ in the sagittal plane,
and placed 7.5mm anterior to bregma in the midline, with
the hole facing the right side. It was lowered until the
tip reached the base of the skull, 2-3mm anterior to the
chiasma (about 10 to 12mm from the brain surface) and
retracted0.5mm. Loss of CSF andbleeding fromthe midline
vessels were prevented by plugging the burr hole with bone
wax before inserting the needle. The amount of 0.3mL
nonheparinized fresh autologous arterial blood was slowly
injected into the prechiasmatic cistern for 20 seconds under
aseptictechnique.Controlanimalswereinjectedwith0.3mL
saline. The animals were allowed to recover 45min after
SAH.Afteroperationprocedures,theratswerethenreturned
to their cages and the room temperature kept at 23 ± 1◦C.
20mL of 0.9% NaCl was injected subcutaneously right after
the operation to prevent dehydration. Heart rate and rectal
temperature were monitored, and the rectal temperature was
kept at 37 ± 0.5◦C, by using physical cooling (ice bag) when
required, throughout experiments. It was observed in the
present study that inferior basal temporal lobe was always
stained by blood. Hence, the brain tissue adjacent to the
clotted blood was taken to analysis in our study (Figure 1).
Control animals underwent exactly the same procedure
as described above with the exception that no blood was
injected intracisternally.
2.3. Experimental Design. The experimental groups con-
sisted of control (n = 6), SAH (n = 6), SAH + vehicle
(n = 6 ) ,a n dS A H+p r o g e s t e r o n e( n = 6). Rats of
SAH + progesterone group received injections of 16mg/kg
progesterone (4-Pregnene-3, 20-dione, Sigma-Aldrich Inc.,
St. Louis, MO, USA) at post-SAH hours 1, 6, and 24
(intraperitoneally for the ﬁrst and subcutaneously for the
remaining two). Rats of SAH + vehicle group received equal
volumes of vehicle (2-hydroxypropyl-β-cyclodextrin, Sigma-
aldrich Inc., St. Louis, MO, USA) [9] .T h ea n i m a l sw e r e
decapitated at 48h after SAH for tissue assays. The brain
tissue was dissected on ice as described in our previous study
[12], some of which was put into 10% buﬀered formalin,
the others were stored at liquid nitrogen immediately until
use.
2.4. Western Blot Analysis. The frozen brain samples were
mechanically lysed in 20mM Tris, pH 7.6, which contains
0.2% SDS, 1% Triton X-100, 1% deoxycholate, 1mM
phenylmethylsulphonyl ﬂuoride (PMSF), and 0.11IU/mL
aprotinin (all purchased from Sigma-Aldrich, Inc., St. Luis,
MO, USA). Lysates were centrifuged at 12,000 × gf o r
20min at 4◦C. The protein concentration was estimated
by the Bradford method using the Nanjing Jiancheng
(NJJC) protein assay kit (Nanjing Jiancheng Bioengineering
Institute, Nanjing, China). The samples (60μg per lane)
wereseparatedby8%SDS-PAGEandelectrotransferredonto
a polyvinylidene-diﬂuoride (PVDF) membrane (Bio-Rad
Lab, Hercules, CA, USA). The membrane was blocked with
5% skimmed milk for 2h at room temperature, incubated
overnight at 4◦C with primary antibodies directed against
TLR4, phosphorylation-NF-κB, ICAM-1, and MCP-1 (all
fromSantaCruzBiotechnology, SantaCruz, CA,USA)atthe
dilutions of 1:200, 1:150, 1:200, and 1:150, respectively.
The glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
(diluted in 1:6000, Sigma-Aldrich, Inc., St. Luis, MO,
USA) was used as a loading control. After the membrane
was washed for 10min each for six times in PBS+Tween
20 (PBST), it was incubated in the appropriate HRP-
conjugated secondary antibody (diluted 1:400 in PBST)
for 2h. The blotted protein bands were visualized by
enhanced chemiluminescence (ECL) Western blot detection
reagents (Amersham, Arlington Heights, IL, USA) and were
exposed to X-ray ﬁlm. Developed ﬁlms were digitized using
an Epson Perfection 2480 scanner (Seiko Corp, Nagano,
Japan). Optical densities were obtained using Glyko Band-
scan software (Glyko, Novato,CA, USA). The tissue of six
animals was used for Western blot analysis at each time
point. All experiments have been repeated at least three
times.Mediators of Inﬂammation 3
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Figure 1: Schematic representation of the areas taken for assay. (a) Control rat brain; (b) SAH rat brain.
2.5.ImmunohistochemicalStudy. Immunohistochemistryon
formalin-ﬁxed paraﬃn-embedded sections was performed
to determine the immunoreactivity of TLR4, NF-κB, and
MCP-1. Sections were deparaﬃn i z e da n dr e h y d r a t e di n
graded concentrations of ethanol to distilled water. Endoge-
nous peroxidase activity was blocked with 3% H2O2 for
5min, followed by a brief rinse in distilled water and a
15min wash in PBS. Sections were placed in 10mmol/L
citrate buﬀer (pH 6.0), and heated in microwave oven at
95◦C for 30min. Sections were cooled at room temperature
for 20min and rinsed in PBS. Nonspeciﬁc protein binding
was blocked by 40min incubation in 5% horse serum. Sec-
tions were incubated with primary antibodies (anti-TLR4,
anti-phosphorylation-NF-κB, and anti-MCP-1, all diluted
1:200, from Santa Cruz Biotechnology, Inc., California,
USA) for 1h at room temperature, followed by a 15min
wash in PBS. Sections were incubated with horseradish
peroxidase (HRP)-conjugated IgG (1:500 dilution, Santa
Cruz Biotechnology, Inc., California, USA) for 60min at
room temperature. DAB was used as chromogen and coun-
terstaining was done with hematoxylin. Sections incubated
in the absence of primary antibody were used as negative
controls.
2.6. Enzyme-Linked Immunosorbent Assay (ELISA). The
frozen brain tissue was homogenized with a glass homoge-
nizerin1mLofbuﬀercontaining1mmol/LofPMSF,1mg/L
of pepstatin A, 1mg/L of aprotinin, and 1mg/L of leupeptin
in PBS solution (pH 7.2) and centrifuged at 12,000g for
20minat4◦C.Thecerebrallevelsofinﬂammatorymediators
were quantiﬁed using speciﬁc ELISA kits for rats according
to the manufacturers’ instructions (TNF-α from Diaclone
Research, France; IL-1β, IL-6 from Biosource Europe SA,
Belgium) [13]. The cytokine contents in the cortex tissue
were expressed as nanograms of cytokines per gram of
protein.
Table 1: Behavior and activity scores.
Category Behavior Score
Appetite
Finished meal 0
Left meal unﬁnished 1
Scarcely ate 2
Activity
Walk and reach at least three corners of
the cage 0
Walk with some stimulations 1
Almost always lying down 2
Deﬁcits
No deﬁcits 0
Unstable walk 1
Impossible to walk 2
2.7. Neurologic Scoring. Three behavioral activity examina-
tions (Table 1) were performed at 24 hours after SAH using
the scoring system reported previously to record appetite,
activity and neurological deﬁcits [14].
2.8.BrainWaterContent. Brainedemawasdeterminedusing
the wet/dry method as previously described where % brain
water = [(wet weight − dry weight)/wet weight] × 100%.
Brieﬂy, brain samples were rapidly removed from the skull
and placed separately into preweighed and labeled glass vials
andweighed.Thevialswerethenplacedinanovenfor72hat
100◦C and then reweighed to obtain dry weight content. The
number of animals used in each group for brain edema study
wascontrol(n = 6),SAH(n = 6),SAH+vehicle(n = 6)and
SAH + progesterone (n = 6).
2.9. Blood-Brain Barrier Permeability. Blood-brain barrier
(BBB) permeability was determined by Evans blue (EB)4 Mediators of Inﬂammation
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Figure 2: (a) Representative autoradiogram of TLR4, NF-κB, ICAM-1, and MCP-1 in the cortex. We observed TLR4 at 89kDa, NF-κBa t
65kDa, ICAM-1 at 59kDa, MCP-1 at 14kDa, and a loading control GAPDH at 37kDa. Lane 1, control group; Lane 2, SAH groups; Lane 3,
SAH + vehicle group; Lane 4, SAH + progesterone group. It shows that the expression of TLR4/NF-κB related proteins increased after SAH
and inhibited by progesterone administration. (b) Quantitative analysis of the Western blot results for TLR4, NF-κB, ICAM-1, and MCP-1.
It shows that the levels of TLR4, NF-κB, ICAM-1, and MCP-1 in SAH groups are signiﬁcantly higher than that in control. After progesterone
administration, the TLR4/NF-κB related agents were signiﬁcantly down-regulated as compared with SAH + vehicle group. Bars represent
the mean ± SD (n = 6, each group). ∗P<. 05 compared with control group, ∗∗P<. 01 compared with control group, #P<. 05 compared
with SAH + vehicle group, ##P<. 01 compared with SAH + vehicle group, nsP>. 05 compared with SAH group.
extravasation at 48h after SAH. Brieﬂy, 2% Evans blue was
injected intravenously at a dose of 2mL/kg. Animals were
then reanesthetized after 1h with urethane (1000mg/kg)
and perfused using saline to remove intravascular EB dye.
Animals were then decapitated, the brains removed and
homogenized in phosphate buﬀered saline. Trichloroacetic
acid was then added to precipitate protein, and the samples
were cooled and centrifuged. The resulting supernatant
was measured for absorbance of EB at 610nm using a
spectrophotometer. The number of animals used in each
group for brain edema study was control (n = 6), SAH (n =
6), SAH + vehicle (n = 6) and SAH + progesterone (n = 6).
2.10. Statistical Analysis. All data except neurologic scoring
were presented as mean ± SD. SPSS 12.0 was used for
statistical analysis of the data. The Mann-Whitney U-test
was used to compare the behavior and activity score among
groups. The other measurements were analyzed by one-way
analysis of variance (ANOVA) or Student’s t-test. Statistical
signiﬁcance was inferred at P<. 05.
3. Results
3.1. General Observation. There were no signiﬁcant diﬀer-
ences in body weight, temperature, or injected arterial blood
gas data among the experimental groups (P>. 05, ANOVA,
data not shown). After induction of SAH, all animals will
stop breathing for about 30 seconds. The mortality rate of
rats in the control group was 0 (0/18 rats), and it was 31%
(24/78 rats) in the SAH group.
3.2. Western Blot Analysis for Detecting TLR4, NF-κB, ICAM-
1, and MCP-1 Expressions after SAH. The protein levels of
TLR4,NF-κB,ICAM-1,andMCP-1weredetectedbywestern
blot. These proteins were expressed at a low level in the rat
brainsofcontrolgroup.ThelevelsofTLR4,NF-κB,ICAM-1,
and MCP-1 were signiﬁcantly increased in the cortex in SAH
group as compared with that of sham-operated groups (P<
.01). The protein expressions had no signiﬁcant diﬀerence
between SAH group and SAH + vehicle group (P>. 05).
TheexpressionsofTLR4,NF-κB,ICAM-1,andMCP-1inthe
brains of SAH + progesterone group were signiﬁcantly lower
than those of the SAH + vehicle group (Figure 2).
3.3. Immunohistochemistry for TLR4, NF-κB, and MCP-
1 Expressions after SAH. To assess the localization of
TLR4/NF-κB pathway, immunohistochemistry for TLR4,
NF-κB, and MCP-1 was performed. A few TLR4, NF-κB, or
MCP-1 positive cells were observed in the control group,
which indicates the constitutional activity of TLR4/NF-κB
pathway in the control brain of rats (Figure 3). Increased
positive cells in the SAH groups could be found in the brain
samples (Figure 3). These proteins’ immunoreactivity was
mainly present in neurons and a little in glia cells (Figure 3).
In SAH + progesterone group, the number of positive cells
was decreased (Figure 3).
3.4. Eﬀect of Progesterone on Concentrations of IL-β,T N F -
α and IL-6 in SAH Brains. Concentrations of IL-1β,T N F -
α and IL-6 were low in the rat brains of control group
(5.39 ±2.18, 0.49 ±0.19 and 0.18 ±0.06ng/g protein, resp.,)
(Figure 4). Compared with control group, cortical levels of
the three inﬂammatory cytokines were greatly induced after
SAH. As shown in Figure 4, progesterone administration
after SAH could lead to signiﬁcantly decreased IL-1β,T N F - α
and IL-6 concentrations.Mediators of Inﬂammation 5
Figure 3: Continued.6 Mediators of Inﬂammation
Figure 3: Immunohistochemical study of TLR4, NF-κB, and MCP-1 on brain samples in (scale bar, 100μm). The arrows show the positive
neurons.
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Figure 4: Changes of inﬂammatory mediators in the injured
brains as determined by ELISA in control group (n = 6), SAH
group (n = 6), SAH + vehicle group (n = 6), and SAH +
progesterone group (n = 6). SAH could induce the signiﬁcantly
increased concentrations of IL-1β,T N F - α and IL-6 in the rat brain
surrounding the blood clot. In SAH + progesterone group, the
cortical concentrations of IL-1β,T N F - α and IL-6 were markedly
down-regulatedascomparedwiththatofSAH+vehiclegroup.Bars
represent the mean ± SD (n = 6, each group). ∗∗P<. 01 compared
with control group, #P<. 05 compared with SAH + vehicle group,
##P<. 01 compared with SAH + vehicle group, nsP>. 05 compared
with SAH group.
3.5. Impact of Progesterone on Clinical Behavior Function after
ExperimentalSAH. Ascomparedwithcontrolgroup,clinical
behaviorfunctionimpairment causedbySAHwasevidentin
SAHsubjects(P<. 01,Table 2).Nosigniﬁcantdiﬀerencewas
seen between the SAH group and SAH + vehicle group (P>
.05). Progesterone treated rats showed better performance in
this scale system than vehicle-treated rats at 24h after SAH
(Table 2), and the diﬀerence was statistically signiﬁcant (P<
.01, Table 2).
Table 2: Clinical behavior scales in each group.
Group Mean score
Control (n = 6) 0.5
SAH (n = 6) 2.5∗∗
SAH + vehicle (n = 6) 2.7ns
SAH + progesterone (n = 6) 1.7##
∗∗P<. 01 compared with control group.
nsP>. 05 compared with SAH group.
##P<. 01 compared with SAH + vehicle group.
3.6. Progesterone-Ameliorated Cerebral Oedema after Experi-
mental SAH. Signiﬁcant increase (P<. 05) in water content
was detected in the brain samples at 48h after SAH when
compared with rats in control group (Figure 5). The mean
value of brain water content in the cortex was decreased by
progesterone administration (P<. 05) as compared with
SAH+vehiclegroup.Theresultssuggestedthatprogesterone
treatment could attenuate brain edema in this rat SAH
model.
3.7. Inﬂuence of Progesterone on the Blood-Brain Barrier
Permeability Following SAH. The pattern of Evans blue
extravasation following SAH is shown in Figure 6.R a t si n
SAH + vehicle group demonstrated a signiﬁcant increase
(P<. 01) inBBBpermeabilityto Evansbluerelativetoratsof
control group. Administration of progesterone signiﬁcantly
inhibited Evans blue extravasation (P<. 05), indicating a
reducedBBB opening in response to progesterone treatment.
4. Discussion
The main ﬁndings of this study are as follows: (1) TLR4
and NF-κB proteins were up regulated remarkably following
SAH; (2) the levels of IL-β,T N F - α, IL-6, ICAM-1 and MCP-
1inthebrainweresigniﬁcantlyincreasedafterprechiasmatic
blood injection; (3) the cortical levels of these agents related
to TLR4/NF-κB signaling pathway were suppressed when
treated with progesterone; (4) after progesterone adminis-
tration, EBI was signiﬁcantly ameliorated. These ﬁndings
suggest for the ﬁrst time that progesterone may attenuateMediators of Inﬂammation 7
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Figure 5: Alterations in brain water content in control group
(n = 6), SAH group (n = 6), SAH + vehicle group (n = 6),
and SAH + progesterone group (n = 6). The brain water content
was increased signiﬁcantly at 48h after SAH. The progesterone
treatment markedly reduced brain water content. No diﬀerence of
brain water content was detected between SAH and SAH + vehicle
groups ∗P<. 05versuscontrolgroup, #P<. 05versusSAH+vehicle
group, nsP>. 05 versus SAH group.
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Figure 6: Alterations in Evans blue extravasation in control group
(n = 6),SAHgroup(n = 6),SAH+vehiclegroup(n = 6),andSAH
+ progesterone group (n = 6). SAH could induce a marked increase
of BBB extravasation in the rat brain compared with control group.
Afterprogesteroneadministration,theEvansblueextravasationwas
signiﬁcantly reduced as compared with SAH + vehicle group. ∗∗P<
.01versuscontrolgroup, #P<. 05versusSAH+vehiclegroup, nsP>
.05 versus SAH group.
the SAH-induced TLR4/NF-κB signaling pathway activation
that may facilitate the development of EBI following SAH in
rats.
The researchers began to examine the direct role of
progesterone as a therapeutic agent in brain injury by trying
to account for observations that females sometimes recover
better from TBI compared with males and it was proved by
an experimental animal study from Attella et al. [15]a n da
clinical study from Groswasser et al. [16]. Over the past 20
years, several animal studies about TBI have suggested that
progesterone modulated excitoxicity [17–19], reconstituted
the blood brain barrier [20, 21], reduced cerebral edema
[22, 23], decreased neuronal loss, and enhanced recovery
[24]. Moreover, Clinical trials [25, 26] also showed that
moderate brain trauma survivors who received progesterone
were more likely to have a moderate to good outcome
than those randomized to placebo and no serious adverse
events were attributed to progesterone. In this current
study, we found that progesterone administration following
SAH could improve clinical behavior function and decrease
the degree of brain edema and BBB impairment, which
was never demonstrated in the previous research. And
also, none of previous studies focused on the inﬂuence of
progesterone on TLR4/NF-κB signaling pathway related to
cerebral inﬂammation after SAH.
The family of TLRs plays a key role in controlling innate
immunity that responds to a wide variety of pathogen-
associated molecules [27]. A variety of TLRs have been
identiﬁed in human cells and some other species’ brain
[28, 29]. Several studies have suggested that TLR4 is critical
for lipopolysaccharide-induced injury in the central nervous
system [28, 30]. Both endothelial and smooth muscle cells
of the blood vessels in the brain also express TLR4 and
can respond to stimulation [31, 32]. Thus the TLR4 is
well positioned in the central nervous system and seemed
possibly to initiate inﬂammation following SAH. The TLRs-
mediated intracellular signaling pathways converge to acti-
vate NF-κB and c-Jun N-terminal kinases (JNKs), which
induce the transcription of a series of cytokine/chemokine
genes that are involved in the initiation or regulation
of the inﬂammatory response. Although the results of
the present study suggested that the level of TLR4/NF-
κB pathway in the brain was increased following SAH
and could be suppressed after progesterone administration,
the potential mechanism underlying the initial eﬀect on
TLR4/NF-κB signaling pathway following SAH remains
unclear.
As mentioned in Section 1, a lot of endogenous ligands
have been found for TLRs, including heat shock proteins,
double-strand RNA, high-mobility group box 1 (HMGB1)
protein, surfactant proteins A and D, hyaluronan and
ﬁbrinogen [33], some of which have been reported to
become present or elevated in the CSF and brain after SAH
[34, 35]. However, the principal TLR4 ligand in the brain
after SAH and the mechanisms responsible for the beneﬁcial
eﬀects of progesterone call for further research. These TLRs
ligands were released from damaged, dead or ruptured cells
in response to tissue damage, injury and/or infection [35].
The TLR4/NF-κB pathway activation is thought, at least
in part, to be caused by the extravasated blood, the acute
CBF reduction and the induced increase in necrotic cells.
We tentatively put forward that the endogenous danger
signals released from extravasated blood in EBI might be
recognized through TLR4 and perhaps other TLRs to initiate
inﬂammatory responses.
To the best of our knowledge, this is the ﬁrst study to
demonstrate the eﬀect of progesterone on the TLR4/NF-
κB signaling pathway in the brain after SAH. We found
that SAH could upregulate expressions of TLR4 and NF-
κB, levels of IL-β,T N F - α and IL-6, MCP-1, and ICAM-1
expression in the surrounding brain of blood clot, which
couldbemarkedlyinhibitedbyprogesteroneadministration.
These results suggest that SAH could induce an activa-
tion of TLR4/NF-κB signaling pathway that might play a
central role in the inﬂammatory response that leads to
secondary insults after SAH. The therapeutic beneﬁt of
post-SAH progesterone administration might be due to
its salutary eﬀect on modulating TLR4/NF-κB signaling
pathway.8 Mediators of Inﬂammation
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